居住于弱势社区可能增加早发性结直肠癌患者的特异性死亡风险
Early-onset colorectal cancer patients from disadvantaged neighborhoods may have higher cancer-specific mortality
基于肯塔基州和佐治亚州2011至2022年癌症登记数据及2022年社会脆弱性指数(SVI)的回顾性分析显示,居住在社会弱势群体社区与居住在社会优势群体社区的早发性结直肠癌患者相比,其特异性死亡风险高出30%。
Between 2011 and 2022, patients from the most disadvantaged neighborhoods in Kentucky and Georgia who were diagnosed with early-onset colorectal cancer (CRC) had a 30% increased risk of CRC-specific death compared with those from the most advantaged neighborhoods, according to a study presented at the 19th AACR Conference on The Science of Cancer Health Disparities, held Oct. 18–21, 2026.
Both incidence and mortality rates of early-onset CRC, which is typically defined as cases in individuals under 50, have been on the rise in recent years. Given the increasing burden of this cancer, it is important to understand whether social determinants of health—or the conditions in which people live, work and play—are significant contributors to early-onset CRC outcomes, said study presenter Justin Xavier Moore, Ph.D., MPH, who is an associate professor within the Center for Health Engagement and Transformation at the University of Kentucky College of Medicine and an assistant director of population science in the Department of Internal Medicine.
Moore explained that both Kentucky and Georgia have large underserved populations affected by early-onset CRC, with a previous study conducted by his team identifying certain counties in these states as "hot spots" for early-onset CRC mortality. His team wanted to better understand whether any social vulnerability factors—such as income, housing and transportation—were associated with early-onset CRC time to treatment and survival in these states.
"Understanding this relationship will help elucidate which communities are possibly disproportionately affected and allow for resource allocation and risk prevention in vulnerable communities," Moore said.
Moore worked with Meng-Han (Mina) Tsai, Ph.D., an assistant professor at the Georgia Prevention Institute and Augusta University, and other colleagues to analyze 2011–2022 data from 68,789 patients with CRC in the Kentucky (31.2%) and Georgia (68.8%) cancer registries in association with data from the 2022 Social Vulnerability Index (SVI).
The SVI, developed by the Centers for Disease Control, is a composite measure of community-level disadvantage determined by census data among U.S. populations. While it is composed of about 16 factors, it is broken down into four domains: socioeconomic status, household composition, minority status, and housing and transportation. Associations were evaluated using models that adjusted for sociodemographic and clinical factors, including age, SVI domains, sex, race, marital status, insurance status, geographic location, stage at diagnosis and year of diagnosis. Among the patients, 13.6% were diagnosed with early-onset CRC.
Overall, all patients with early-onset CRC, regardless of where they lived in those two states, had a better CRC-specific survival rate, with a five-year CRC mortality rate that was 27% lower than that of patients with average-onset CRC. However, living in disadvantaged areas compared with advantaged areas—as determined by SVI as a whole—was associated with a 30% increased risk of five-year CRC death for patients with early-onset CRC. This was nearly double the 16% increased risk seen among patients with average-onset CRC from disadvantaged areas compared with those in advantaged areas.
When looking at each of the four SVI domains individually, only socioeconomic status and housing/transportation were significantly associated with increased five-year CRC-specific mortality. Living in neighborhoods with disadvantaged socioeconomic status was associated with an increased risk of CRC death of 14% in patients with CRC overall, 21% in patients with early-onset CRC and 13% in patients with average-onset CRC. The risk increases associated with living in neighborhoods with disadvantaged housing/transportation were 8%, 17% and 7%, respectively.
In terms of time to treatment, patients with CRC from socially disadvantaged areas were 4% less likely to initiate treatment within 30 days of diagnosis. However, patients with early-onset CRC received their first treatment sooner than patients with average-onset CRC (after five days vs. after six days).
"One interpretation of our findings is that neighborhood disadvantage may not necessarily be associated with how quickly treatment starts, but it may become increasingly consequential as patients, and particularly younger patients, navigate the many demands of cancer treatment and survivorship over time," Moore explained.
"Socioeconomic and housing/transportation disadvantages may have cumulative effects on a patient's ability to consistently access and remain engaged in cancer care—including attending appointments, completing recommended treatment, managing side effects, accessing supportive services and receiving appropriate follow-up and surveillance. Patients living in more socioeconomically advantaged neighborhoods may have greater resources and fewer logistical barriers that help support continuity of care over time."
Moore added that it is also likely that younger patients overall have better prognoses and survival because they are less likely to have comorbidities and other preexisting conditions compared with average-onset patients. He said it is also plausible that younger patients diagnosed with CRC are now being recommended to start treatment as soon as possible given the rising trend of younger people dying from this disease. However, he noted that further research is needed to better understand and confirm the specific factors leading to more timely treatment and better outcomes for some patients.
In the meantime, transportation assistance and patient navigation programs can further reduce logistical barriers to accessing care, and policies that support paid time off or greater workplace flexibility may also make it easier for patients to attend medical appointments and complete treatment, Moore said.
"Ultimately, reducing these disparities requires recognizing that cancer outcomes are influenced not only by what happens inside the clinic, but also by whether people have the resources and opportunities necessary to access and remain engaged in care," he added.
Limitations of the study include limited generalizability to areas outside of Kentucky and Georgia. Since the study used case-only data from two racially diverse U.S. states, it also limited the researchers' ability to examine causal mechanisms regarding cancer incidence/etiology.
Additionally, the 2022 measures of SVI were based on patients' addresses at diagnosis, which may result in misclassification as people could have varying SVI neighborhood exposures over the course of their lives. SVI measures are also derived from CDC census data, so it is likely that neighborhood contexts are much different than the estimated disadvantage/advantage.
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Early-onset colorectal cancer patients from disadvantaged neighborhoods may have higher cancer-specific mortality (2026, October 19) retrieved 19 October 2026 from https://medicalxpress.com/news/2026-10-early-onset-colorectal-cancer-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com